Browsing: Stock

Hims & Hers Health (HIMS) marked its fifth anniversary as a publicly traded company on Monday, capping a volatile journey that delivered a 314% stock return and turned the former SPAC into a global healthcare business

Novo Nordisk A/S (ISIN DK0062498333) stock is trading in the mid-$40 range for its US-listed ADR as of August 14, 2026, with a closing price of $45.91 and a modest decline of 1.73% on that day, underscoring a period of consolidation after its latest half-year earnings and guidance update. Per recent market data as of…

Amgen Inc. (ISIN US0311621009) stock is trading close to its recent level in mid-August 2026 as investors weigh a higher analyst price target against a strategic reset in the company’s obesity drug pipeline, highlighted on August 17, 2026 by new industry reporting. One recent note lifted the 12?month price objective on Amgen shares to $380,…

With global bond yields high and borrowing costs less forgiving, capital is flowing toward companies that can raise productivity rather than just cut expenses. Transformative AI healthcare stocks sit right in that sweet spot. They use data and algorithms to help doctors work faster and more accurately, which can appeal when every dollar needs to…

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 26.1% over the past six months, topping the S&P 500 by 13.1 percentage points

Eli Lilly (NYSE:LLY)HealthcareEli Lilly and Company (NYSE:LLY)1180.16 USD-28.8402.385%Last Updated at: 2026-08-14T20:09:00Z stock drew attention this week as strong demand for the company’s weight-loss and diabetes treatments lifted its guidance, alongside a European regulatory clearance that advanced its lineup, spotlighting the pharmaceutical company’s momentum across the healthcare sector. The company raised its sales guidance after reporting…

CVS Health (NYSE:CVS)HealthcareCVS Health Corp (NYSE:CVS)97.16 USD+2.1702.285%Last Updated at: 2026-08-14T20:20:00Z stock drew attention this week after the integrated healthcare company reported strong quarterly results, raised its full-year guidance, and expanded its weight-management offerings, even as questions surfaced about part of its pharmacy business, spotlighting its sprawling model across the healthcare sector. The company detailed revenue…

NBC Selected independently determines what we cover and recommend. When you click on or buy through our links, we earn a commission. Learn more

Zealand Pharma stock came into today on a strong run, up 22% over the past month and 10% over three months, with investors leaning into its low 3.7x P/E and fresh profitability over the last year. The earnings release keeps that tension front and center. H1 revenue landed at DKK 4.5b, powered by a DKK…

Novo Nordisk (NYSE:NVO), the Danish obesity-drug giant behind Wegovy and Ozempic, slipped approximately 1% Thursday morning as CEO Mike Doustdar tried to reset the market’s thinking about the obesity race. His pitch: stop treating Novo versus Eli Lilly (NYSE:LLY) like a winner-takes-all fight. The obesity market could top $100 billion annually by 2030, and different…